Ikena Oncology Inc (IKNA)
1.37
-0.04
(-2.84%)
USD |
NASDAQ |
May 08, 16:00
1.38
+0.01
(+0.73%)
Pre-Market: 20:00
Ikena Oncology Shareholders Equity (Quarterly): 169.76M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 169.76M |
| September 30, 2023 | 155.34M |
| June 30, 2023 | 156.70M |
| March 31, 2023 | 135.02M |
| December 31, 2022 | 146.97M |
| September 30, 2022 | 158.79M |
| June 30, 2022 | 174.37M |
| Date | Value |
|---|---|
| March 31, 2022 | 192.96M |
| December 31, 2021 | 207.88M |
| September 30, 2021 | 203.26M |
| June 30, 2021 | 216.26M |
| March 31, 2021 | 227.64M |
| December 31, 2020 | -101.05M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-101.05M
Minimum
Dec 2020
227.64M
Maximum
Mar 2021
157.22M
Average
169.76M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.09M |
| Total Liabilities (Quarterly) | 22.34M |
| Current Ratio | 12.58 |